Condition
Squamous Cell Carcinoma of the Cervix
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownA Study of IDP-001 in Advanced or Metastatic Solid TumorsNCT07602842 · 2026-07-08
RECRUITINGSL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasNCT03894618 · 2019-03-26
COMPLETEDPEN-866 in Patients With Advanced Solid MalignanciesNCT03221400 · 2017-08-29
UNKNOWNA Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerNCT02042885 · 2014-01-01
TERMINATEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED1
RECRUITING1
TERMINATED1
UNKNOWN1
Phase mix
PHASE14
PHASE23
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.